Next Article in Journal
Japan’s Practical Guidelines for Zinc Deficiency with a Particular Focus on Taste Disorders, Inflammatory Bowel Disease, and Liver Cirrhosis
Previous Article in Journal
Amino-Functionalized Nitrogen-Doped Graphene-Quantum-Dot-Based Nanomaterials with Nitrogen and Amino-Functionalized Group Content Dependence for Highly Efficient Two-Photon Bioimaging
Previous Article in Special Issue
Altered Structural Expression and Enzymatic Activity Parameters in Quiescent Ulcerative Colitis: Are These Potential Normalization Criteria?
Open AccessReview

Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse

1
Postgraduate Program in Structural and Functional Interactions in Rehabilitation, University of Marilia (UNIMAR), Avenue Hygino Muzzy Filho, 1001, Marília 17525902, São Paulo, Brazil
2
School of Medicine, University of Marília (UNIMAR), Avenida Higino Muzzi Filho, 1001, Marília 17525902, São Paulo, Brazil
3
Department of Biochemistry and Nutrition, Faculty of Food Technology of Marília, Marília 17525902, São Paulo, Brazil
4
Department of Animal Sciences, School of Veterinary Medicine, University of Marília (UNIMAR), Avenida Higino Muzzi Filho, 1001, Marília 17525902, São Paulo, Brazil
5
Bauru School of Dentistry, Department of Biological Sciences, University of São Paulo (FOB–USP), Alameda Doutor Octávio Pinheiro Brisolla, 9-75, Bauru 17040, São Paulo, Brazil
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(8), 2940; https://doi.org/10.3390/ijms21082940
Received: 10 March 2020 / Revised: 7 April 2020 / Accepted: 20 April 2020 / Published: 22 April 2020
(This article belongs to the Special Issue Update on Basic and Molecular Research in Inflammatory Bowel Disease)
Inflammatory bowel diseases (IBD) are characterized by a chronic and recurrent gastrointestinal condition, including mainly ulcerative colitis (UC) and Crohn’s disease (CD). Cannabis sativa (CS) is widely used for medicinal, recreational, and religious purposes. The most studied compound of CS is tetrahydrocannabinol (THC) and cannabidiol (CBD). Besides many relevant therapeutic roles such as anti-inflammatory and antioxidant properties, there is still much controversy about the consumption of this plant since the misuse can lead to serious health problems. Because of these reasons, the aim of this review is to investigate the effects of CS on the treatment of UC and CD. The literature search was performed in PubMed/Medline, PMC, EMBASE, and Cochrane databases. The use of CS leads to the improvement of UC and CD scores and quality of life. The medical use of CS is on the rise. Although the literature shows relevant antioxidant and anti-inflammatory effects that could improve UC and CD scores, it is still not possible to establish a treatment criterion since the studies have no standardization regarding the variety and part of the plant that is used, route of administration and doses. Therefore, we suggest caution in the use of CS in the therapeutic approach of IBD until clinical trials with standardization and a relevant number of patients are performed. View Full-Text
Keywords: inflammatory bowel disease; ulcerative colitis; Crohn’s disease; cannabis; cannabidiol inflammatory bowel disease; ulcerative colitis; Crohn’s disease; cannabis; cannabidiol
Show Figures

Graphical abstract

MDPI and ACS Style

Carvalho, A.C.A.; Souza, G.A.; Marqui, S.V.; Guiguer, É.L.; Araújo, A.C.; Rubira, C.J.; Goulart, R.A.; Flato, U.A.P.; Bueno, P.C.S.; Buchaim, R.L.; Barbalho, S.M. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse. Int. J. Mol. Sci. 2020, 21, 2940.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop